Abstract
Myxozoan parasites pose huge threat to wild and cultured fishes and reported to cause heavy mortality, retarded growth and post-harvest quality degradation. It is one of the highly divergent groups of parasites which infects skin, gill, muscle, cartilage and internal organs of host fish and the severity of pathology varies depending on the water temperature, species of fish, site of tissue infection and immune resistance of the individual host. Most infections are difficult to treat, as they can easily evade host cellular and humoral defence mechanisms by proliferating or migrating through immune compromised sites of the host and forming large plasmodia encapsulated by the host cellular elements. This spore-forming parasite is harmless to humans but often detected in faecal samples of immunosuppressed humans. The incidences are mostly associated with the consumption of infected fish having a high concentration of spores which causes diarrhea and stomach pain. Currently, there are no immunostimulants or vaccines available for controlling these parasites, however, fumagillin is the drug of choice in fish for controlling this parasitic infection. Excessive usage of fumagillin causes tissue damage and retarded growth in fish, hence feed incorporation of this antibiotic in proper dose is essential for effective treatment. In this review detailed information on the diseases caused by myxozoan parasites in fishes and their zoonotic potential is discussed.